Diffuse large b-cell lymphoma recurrent and Weight decreased
Summary:
Weight decreased is found among people with Diffuse large b-cell lymphoma recurrent, especially for people who are male, 60+ old.
The study analyzes which people have Weight decreased with Diffuse large b-cell lymphoma recurrent. It is created by eHealthMe based on reports of 12 people who have Diffuse large b-cell lymphoma recurrent from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Diffuse large b-cell lymphoma recurrent?
Diffuse large b-cell lymphoma recurrent (recurrent cancer of b cells, a type of white blood cell) is found to be associated with 74 drugs and 90 conditions by eHealthMe. Check the latest studies of Diffuse large b-cell lymphoma recurrent.
What is Weight decreased?
Weight decreased is found to be associated with 3,392 drugs and 4,747 conditions by eHealthMe. Check the latest studies of Weight decreased.
12 people who have Diffuse Large B-Cell Lymphoma Recurrent and Weight Decreased are studied.

Gender of people who have Diffuse Large B-Cell Lymphoma Recurrent and experienced Weight Decreased *:
- female: 50 %
- male: 50 %
Age of people who have Diffuse Large B-Cell Lymphoma Recurrent and experienced Weight Decreased *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs taken by these people *:
- Bendamustine: 5 people, 41.67%
- Vitamin B12: 4 people, 33.33%
- Tradjenta: 4 people, 33.33%
- Remeron: 4 people, 33.33%
- Pantoprazole: 4 people, 33.33%
- Lexapro: 4 people, 33.33%
- Folvite: 4 people, 33.33%
- Amaryl: 4 people, 33.33%
- Cyclophosphamide: 3 people, 25.00%
- Fluconazole: 2 people, 16.67%
Common symptoms for these people *:
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 50.00%
- Malignant Neoplasm Progression (cancer tumour came back): 4 people, 33.33%
- Drug Ineffective: 2 people, 16.67%
- Weakness: 1 person, 8.33%
- Peripheral Sensorimotor Neuropathy (damage to one or more of your peripheral nerves): 1 person, 8.33%
- Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 8.33%
- Nervous System Disorder (a general class of medical conditions affecting the nervous system): 1 person, 8.33%
- Nausea (feeling of having an urge to vomit): 1 person, 8.33%
- Hypersensitivity: 1 person, 8.33%
- Fatigue (feeling of tiredness): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weight decreased?
- Check whether Weight decreased is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Diffuse large b-cell lymphoma recurrent (2,790 reports)
- Weight decreased (364,522 reports)
All the drugs that are associated with Weight decreased:
- Weight decreased (3,392 drugs)
All the conditions that are associated with Weight decreased:
- Weight decreased (4,747 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Weight decreased and Diffuse large b-cell lymphoma recurrent, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Glatiramer Acetate cause Dyspnea? - 5 seconds ago
- Could Codeine Sulfate cause Liver Disorder? - 7 seconds ago
- Could Phenergan cause Pyelocaliectasis? - 8 seconds ago
- Could Tiotropium Bromide cause Total Lung Capacity Decreased? - 9 seconds ago
- Could Olumiant cause Itching? - 12 seconds ago
- Drug interactions of L-Lysine and Carafate - 13 seconds ago
- Could Topamax cause Parasomnia? - 26 seconds ago
- Drug interactions of Fluticasone Propionate and Hydrocodone Bitartrate - 27 seconds ago
- Could Xgeva cause Flank Pain? - 30 seconds ago
- Could Gentak cause Weakness? - 32 seconds ago